Falling profit margins wound Smith & Nephew
Smith & Nephew makes amends to cut costs
Poor orthopaedic trading margin impacts performance
The Share Centre puts ‘hold’ recommendation under review
As Smith & Nephew reports disappointing Q3 figures, Nick Raynor, investment research analyst at The Share Centre, explains what they mean for investors.
“
Smith & Nephew reported sales figures that were largely in line with expectations, with revenue increasing by 10%, and underlying growth rising by 5%. However, poor margins in its orthopaedics side of the business put pressure on the company’s performance. The 15.6% margin, which was short of analyst expectations, was caused by high periodic costs, adverse sales mix and the need to reduce costs to reflect market conditions.
“The company has been attempting to improve margins by cost cutting for some time. However, these figures have shown the cost base is still too high. Although
Smith & Nephew have restructuring plans in place, we doubt these will be implemented by the end of the year, which could see crippling margins impede final year results.
“Concerns remain over the US health system and with no signs of the credit crunch easing, we could see Smith & Nephew’s profitability fall further. The company generates a large proportion of its business from elective procedures, however, as worry over employment remains, people are opting to wait for the national healthcare system.
“The market reacted to these disappointing figures with the share price falling by as much as 6% in early morning trading. Following these results our current ‘hold’ recommendation looks weak and
Smith & Nephew is now under review.”
THIS DATA IS PROVIDED BY THE SHARE CENTRE. THIS IS NOT INTENDED TO CONSTITUTE AN OFFER OR AGREEMENT TO BUY OR SELL INVESTMENTS.
Risk Warnings:
Investing in general, and the products and services mentioned above may not be suitable for all: if in doubt, individuals should seek independent financial advice. The value of investments and the income from them can go down as well as up and investors may not get back their original investment. Past performance is not a reliable indicator of future performance.
The bases and levels of taxation relating to ISAs, CTFs and SIPPs are subject to change and the value of these tax allowances may depend upon the circumstances of the individual.
Moneyextra.com recommends you take independent financial advice before acting on any article
Back2011-11-04 13:07:44 © Moneyextra.com